Kangfeng Jin
机构:Nantong University, Affiliated Hospital of Nantong University
发表论文 10 篇 · 总被引 41 次 · h-index 5
代表论文
- Identification of serum tsRNA-Thr-5-0015 and combined with AFP and PIVKA-II as novel biomarkers for hepatocellular carcinoma (2024 · Scientific Reports · 被引 9)
- ACYP2 functions as an innovative nano-therapeutic target to impede the progression of hepatocellular carcinoma by inhibiting the activity of TERT and the KCNN4/ERK pathway (2024 · Journal of Nanobiotechnology · 被引 9)
- tRNA-Derived Small RNA Accelerates Tumorigenesis through Crosstalk with Tumor-Associated Macrophages, and Downregulation with Cell Membrane-Modified Polymer Nanoparticles Enables Treatment Response (2025 · ACS Applied Materials & Interfaces · 被引 6)
- Identification and potential mechanism of a novel gastric cancer suppressor tRF-24-6VR8K09LE9 (2025 · Naunyn-Schmiedeberg s Archives of Pharmacology · 被引 6)
- TsR-0072 inhibits colorectal cancer progression through modulating lipid and vitamin D 3 metabolic reprogramming and inactivating the Wnt/β-catenin signalling pathway (2025 · Annals of Medicine · 被引 5)
- tRF-23-R9J89O9N9:A novel liquid biopsy marker for diagnosis of hepatocellular carcinoma (2025 · Clinica Chimica Acta · 被引 4)